Nanoplatform strategy for multimodal cancer therapy and tumor visualization

Announcing a new publication for Acta Materia Medica journal. Treatment of cancer can be challenging, because of the disease’s intricate and varied nature.

First Brain-Delivered Gene Therapy Approved for AADC Deficiency

The FDA granted accelerated approval to eladocagene exuparvovec (Kebilidi) to treat children and adults with aromatic L-amino acid decarboxylase (AADC) deficiency, the agency announced Thursday.

November 15, 2024

Brain Edema, Imaging Abnormalities Reported for Alzheimer’s Drug

Donanemab raised the risk of amyloid-related imaging abnormalities (ARIA) in Alzheimer’s patients. Many ARIA events were mild to moderate, asymptomatic, and occurred early in treatment.

March 12, 2025

Sweet drinks, sour outcomes: a global health wake-up call

Sugar-sweetened beverages contribute significantly to global burdens of type 2 diabetes and cardiovascular disease, with disparities driven by age, education, and region. This study emphasizes

January 8, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.